Add BrightSurf on Google Email

How the flu virus hacks our cells

A UNIGE team has identified how the influenza A virus manages to penetrate cells to infect them by hijacking the iron transport mechanism. By blocking this receptor, researchers were able to significantly reduce its ability to invade cells, highlighting a potential strategy for treating influenza virus infections.

SourceUniversité de Genève·JournalProceedings of the National Academy of Sciences·TypeNews article·DateMay 31, 2023

Genetic change increased bird flu severity during U.S. spread

Scientists at St. Jude Children's Research Hospital discovered how the current H5N1 avian influenza virus gained new genes and greater virulence as it spread across North America. The researchers found that the virus could severely infect the brains of mammalian research models, a notable departure from previous related strains.

SourceSt. Jude Children's Research Hospital·JournalNature Communications·TypeExperimental study·DateMay 30, 2023

Study investigates how the severity of effects of the SARS-CoV-2 virus in England was affected by the mass vaccination campaign and emergence of Alpha, Delta and Omicron variants between May 2020 and March 2022

Researchers analyzed hospitalization and fatality rates of SARS-CoV-2 infection in England between May 2020 and March 2022. The study found that the mass vaccination campaign significantly reduced severe effects of the virus, with notable improvements after the emergence of Alpha, Delta, and Omicron variants.

SourcePLOS·JournalPLOS Biology·DateMay 25, 2023

A multiomics approach provides insights into flu severity

Researchers used a multiomics approach to analyze changes in transposable elements after influenza A virus infection, identifying transcription factors contributing to individual responses. The study provides insights into the variable severity of illness among individuals infected with the same virus.

SourceKyoto University·JournalCell Genomics·TypeExperimental study·DateMay 22, 2023

HPV self-collection kits increase screening among under-screened, under-served women in North Carolina

A Phase 3 trial found that mailing HPV self-collection kits and scheduling assistance increased cervical cancer screenings among under-screened, underserved women. The study demonstrated the effectiveness of this approach in breaking down access barriers to screening.

SourceUniversity of North Carolina Health Care·JournalThe Lancet Public Health·TypeRandomized controlled/clinical trial·DateMay 11, 2023

Ancestral mitoviruses discovered in mycorrhizal fungi

Researchers have identified a new group of mitochondrial viruses confined to arbuscular mycorrhizal fungi Glomeromycotina, which may represent an ancestral lineage of mitoviruses. These large duamitoviruses possess distinct characteristics and are globally distributed in ecological niches occupied by glomeromycotinian fungi.

SourceHokkaido University·JournalmBio·TypeExperimental study·DateMay 11, 2023

Home measurement of blood oxygen levels by corona patients themselves easily applicable

A study by UMC Utrecht shows that corona patients can measure their blood oxygen levels at home using a pulse oximeter, feeling safe and experiencing more control. This method does not increase GP visits or hospitalization but contributes to relieving caregivers and keeping healthcare affordable.

SourceUniversity Medical Center Utrecht·JournalBritish Journal of General Practice·TypeRandomized controlled/clinical trial·DateMay 10, 2023

A CRISPR-edited calf shows virus resistance

A gene-edited calf demonstrates reduced susceptibility to bovine viral diarrhea virus (BVDV) after intentionally altering the CD46 receptor with CRISPR/Cas9. The healthy calf showed no measurable infectious virus in its blood, despite both calves developing antibodies to the virus.

SourcePNAS Nexus·JournalPNAS Nexus·DateMay 9, 2023

Scientists from IOCB Prague move closer to developing a drug not only against monkeypox

Researchers deciphered the structure of the protein methyltransferase from the monkeypox virus, identifying a target for antiviral drugs. The findings may lead to the creation of new antivirals effective against not only monkeypox but also COVID-19.

HKUMed finds global prevalence of H. pylori infection steadily declining over 40 years Combination of antibiotics in treating H. pylori could alter the virus community in the gut

The study found that the global prevalence of H. pylori infection declined from 58.2% in 1980-1990 to 43.1% in 2011-2022, with a decline of about 0.39-0.83% per year. Despite this decline, over 40% of the adult population still carries the infection, posing a significant burden on healthcare systems worldwide.

SourceThe University of Hong Kong·JournalThe Lancet·TypeExperimental study·DateApr 24, 2023

What previous bird flu outbreaks teach us

Researchers studied H7N9 epidemic waves in China from 2013 to 2017, analyzing gene sequences to build phylogenetic trees. They found the virus likely circulated in poultry for months before being detected, and suggest continuous monitoring of animal health is crucial

SourceETH Zurich·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateApr 17, 2023

New discovery stops bacterial virus contamination

A new discovery by researchers at the University of Warwick has found a simple material that can prevent bacterial viruses from contaminating laboratories and microbial factories. This breakthrough aims to develop next-generation industrial biotechnologies and remove a bottleneck in fundamental research.

SourceUniversity of Warwick·JournalJournal of the American Chemical Society·DateApr 17, 2023

First Nations populations at greater risk of severe flu, research finds

A new study by the Peter Doherty Institute found that First Nations populations are significantly more likely to be hospitalized and die from influenza compared to non-Indigenous populations. Influenza-associated hospitalization and mortality rates were consistently higher in First Nations communities globally.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalPLOS Global Public Health·TypeMeta-analysis·DateApr 13, 2023

Study predicts poor survival rates if Ebola infects endangered mountain gorillas

A study published in Scientific Reports predicts that less than 20% of endangered mountain gorillas would survive more than 100 days past the first confirmed case of Ebola infection. Vaccination strategies are suggested to increase survival rates, with at least half of habituated gorillas vaccinated within three weeks of confirmation.

SourceUniversity of California - Davis·JournalScientific Reports·TypeComputational simulation/modeling·DateApr 12, 2023

Tick-borne Powassan virus is being transmitted in concentrated clusters in New England, Yale study says

A Yale study found that the tick-borne Powassan virus is being transmitted in concentrated community clusters throughout New England. The research reconstructed the history of Powassan in the region and estimated when branches of the virus's 'family tree' diverged, piecing together its evolution and spread.

SourceYale School of Public Health·JournalProceedings of the National Academy of Sciences·DateApr 11, 2023

Vaccination during pregnancy could prevent RSV illness in infants

A clinical study has shown that vaccination during pregnancy can effectively prevent severe respiratory syncytial virus (RSV) disease in infants. The vaccine was found to be well-tolerated and provided over 80% protection against RSV illness, with benefits expected for vulnerable populations worldwide.

SourceCharité - Universitätsmedizin Berlin·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 6, 2023

We've learned a lot from lymphocytic choriomeningitis virus—now the time has come to fight it

Researchers at La Jolla Institute for Immunology have developed a high-resolution view of the LCMV glycoprotein, revealing its structure and potential vulnerabilities. The breakthrough enables the development of an engineered antibody that can prevent LCMV disease, offering a new route to treatment.

SourceLa Jolla Institute for Immunology·JournalCell Chemical Biology·TypeExperimental study·DateMar 28, 2023

New mosquito species reported in Florida

A new mosquito species, Culex lactator, has been found in Florida, with thriving populations reported in three counties. Scientists are concerned about the potential for this species to transmit diseases, particularly given the lack of research on its disease risk.

SourceUniversity of Florida·JournalJournal of Medical Entomology·DateMar 22, 2023

An extra X chromosome-linked gene may explain decreased viral infection severity in females

A study published in Nature Immunology found that female mouse and human NK cells have more of a specific epigenetic regulator called UTX, which boosts anti-viral function while repressing NK cell numbers. This suggests that therapies need to be tailored to individual differences, including sex.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Immunology·TypeExperimental study·DateMar 16, 2023

Bird flu associated with hundreds of seal deaths in New England in 2022, Tufts researchers find

A new study from Cummings School of Veterinary Medicine at Tufts University found that highly pathogenic avian influenza (HPAI) was associated with the deaths of over 330 New England harbor and gray seals. The virus was detected in birds and seals on the same beach, highlighting a potential route of transmission.

SourceTufts University·JournalEmerging Infectious Diseases·TypeObservational study·DateMar 15, 2023

How the Brain Senses Infection

A study published in Nature found that a small group of neurons in the airway play a pivotal role in alerting the brain about flu infections. The researchers also identified a second pathway from the lungs to the brain that becomes active later in the infection, which may hold promise for developing new treatments.

SourceHarvard Medical School·JournalNature·DateMar 8, 2023

Study reinforces potential use of zika virus to combat prostate cancer but points to possible side-effect

Researchers analyzed zika virus effects on tumor cells and healthy cells, discovering its potential to treat prostate cancer but also triggering a persistent inflammatory process that damages the male reproductive system. The study's findings suggest long-term treatment could lead to recurrence of prostate cancer.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalJournal of Proteome Research·DateMar 1, 2023

Oral bacteria may increase heart disease risk

A study published in eLife has linked infection with the bacterium Fusobacterium nucleatum to an increased risk of cardiovascular disease. The researchers found that individuals with high genetic risk scores for coronary heart disease were at elevated risk for cardiovascular events.

SourceeLife·JournaleLife·DateFeb 14, 2023

Why men are at higher risk from COVID-19

Researchers at Osaka University found that male patients with COVID-19 have a faster loss of circulating Treg cells, leading to dysregulated antibody responses. Females, on the other hand, have higher levels of these cells, which may help protect them from infection.

SourceOsaka University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 12, 2023

How hepatitis E viruses enter cells

A study published in Hepatology reveals that the EGFR protein plays a crucial role in the entry mechanism of hepatitis E virus into human hepatocytes. The researchers found that suppressing the activity of the EGFR protein significantly reduced cell infections, suggesting potential therapeutic applications for approved cancer drugs.

SourceRuhr-University Bochum·JournalHepatology·TypeExperimental study·DateFeb 9, 2023

Harnessing an innate protection against Ebola

School of Veterinary Medicine researchers have identified a cellular pathway that hampers the Ebola virus' ability to exit human cells. By targeting the protein VP40, host cells activate autophagy, a process that digests and recycles proteins, reducing viral particle release into the bloodstream.

SourceUniversity of Pennsylvania·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 3, 2023